Fusion protein for treating diabetes and/or obesity
A fusion protein and protein technology, which is applied in the fusion of peptide/protein components, animal/human proteins, and prolonging the life of plasma, can solve the problems of easy degradation and aggregation, high cost, toxic and side effects, etc., and improve the hypoglycemic activity , weight loss, high solubility effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0056] Example 1: Linking GLP-1 to different ABD domains
[0057] 1. Vector construction
[0058] The fusion protein gene of ABD and GLP-1 was obtained by whole gene synthesis, wherein GLP-1 was connected to the N-terminal or C-terminal of ABD and connected to pET-24d to construct pET-24d-GLP-ABD-X-Ln or pET-24d-ABD-GLP-X-Ln (X represents GS linking peptide or EA linking peptide; n=0, 1, 2, 3 repeats of GGGGS or EAAAK); all target proteins contain His at the N-terminus -tag and TEV protease cleavage site, MKHHHHHHPMSDYDIPTTENLYFQ (SEQ ID NO.34).
[0059] GLP-1 sequence (31 amino acids) :
[0060] HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG (SEQ ID NO. 1)
[0061] or HSEGTFTSDVSSYLEGQAAKEFIAWLVKGRG (SEQ ID NO.2)
[0062] GA3 sequence (SEQ ID NO.3)
[0063] LAEAKVLANRELDKYGVSDYYKNLINNAKTVEGVKALIDEILAALP
[0064] ABD035 sequence (SEQ ID NO.4)
[0065] LAEAKVLANRELDKYGVSDFYKRLINKAKTVEGVEALKLHILAALP
[0066] ABDCon sequence (SEQ ID NO.5)
[0067] LKEAKEKAIEELKKAGITSDYYFDLINKAKT...
Embodiment 2
[0112] Example 2: Linking exenatide (Ex) to different ABD domains
[0113] 1. Vector construction
[0114] The fusion protein genes of various ABD and Ex were obtained by whole gene synthesis, and exenatide (Ex) was connected to the N-terminal or C-terminal of ABD, and then connected to the expression vector pET-24d, etc., to construct pET-24d- Ex-ABD-X-Ln or pET-24d-ABD-Ex-X-Ln (X represents GS-linked peptide or EA-linked peptide; n=0, 1, 2, 3 repeats of GGGGS or EAAAK); in all purposes The N-terminus of the protein all contains a His-tag and a TEV protease cleavage site, MKHHHHHHPMSDYDIPTTENLYFQ (SEQ ID NO.34).
[0115] Exenatide (Ex) sequence (39 amino acids): (SEQ ID NO. 24)
[0116] HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
[0117] Ex-GA3-GS-L2 sequence (SEQ ID NO. 25)
[0118] HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSGSGGGGSGGGGSLAEAKVLANRELDKYGVSDYYKNLINNAKTVEGVKALIDEILAALP
[0119] Ex-GA3-GS-L3 sequence (SEQ ID NO. 26)
[0120] HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPS...
Embodiment 3
[0129] Example 3: Linking GLP-1 or Exenatide Ex to DARPin protein
[0130] 1. Vector Construction
[0131] Link GLP-1 or Ex to the N-terminus of DARPin by gene fusion, synthesize all the genes by whole gene synthesis, and link them with the expression vector pET-28a to construct the expression vector pET-28a-GLP-DARPin -GS-L3 or pET-28a-Ex-DARPin-GS-L3, etc.;
[0132] The two DARPins were connected in series, and GLP-1 was linked to its N-terminus to construct the expression vector pET-28a-GLP-DARPin-DARPin-GS-L3. The two DARPins are linked by GTGPTPTPTGSGPTPTPTGGS (SEQ ID NO.35) sequence.
[0133] The N-terminals of all target proteins contain His-tag and TEV protease cleavage site, MGSSHHHHHHSSGENLYFQ (SEQ ID NO.36).
[0134] DARPin sequence: (SEQ ID NO.30)
[0135] DLGKKLLEAARAGQDDEVRELLKAGADVNAKDYFSHTPLHLAARNGHLKIVEVLLKAGADVNAKDFAGKTPLHLAANEGHLEIVEVLLKAGADVNAQDIFGKTPADIAADAGHEDIAEVLQKAA
[0136] GLP-DARPin-GS-L3 sequence; (SEQ ID NO. 31)
[0137] HGEGTFTSDVSSYLEG...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com